PRISM uses innovative peptide mimic technology to create therapeutic drugs that effectively treat challenging diseases. Their mission is to develop cures for these conditions through advanced research and development.

Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of ​​cancer with high unmet medical need.

Scohia Pharma is a cutting-edge biotech startup with a focus on research and development. With substantial resources, they aim to revolutionize the industry through innovative solutions.

FIMECS is dedicated to creating innovative protein degradation therapies for challenging diseases like cancer. Their focus is on developing cutting-edge treatments that target specific proteins to improve outcomes for patients.

K-Pharma creates pharmaceuticals by utilizing early-stage neuro regenerative medicine and iPS drug discovery. They also research, manufacture, and develop medical products and pharmaceuticals.

GEXVal supports patients and families battling orphan and intractable diseases.

Reborna Biosciences is a cutting-edge startup dedicated to researching and developing treatments for rare genetic diseases. Their focus is on creating innovative solutions to improve the lives of individuals affected by these conditions.

Log build offers a new form of on-site management that enables productivity improvement and real-time visualization and sharing of on-site information through on-site management robots and VR software.

Catalys Pacific, founded in 2019, is an independent venture capital firm specializing in early-stage investments in life sciences. Their focus is on creating and investing in bioventure companies to provide innovative healthcare solutions for patients globally.

Aculys Pharma innovates advanced medical solutions for patients, focusing on superior methods. Their goal is to develop and deliver cutting-edge treatments to improve patient outcomes.

SEEDSUPPLY research and develops medical and agricultural chemical products. The company is a spin-off of Takeda Pharmaceutical Company Limited and established in May 2017 and is headquartered in Fujisawa, Kanagawa, Japan.

Scohia Pharma is a cutting-edge biotech startup with a focus on research and development. With substantial resources, they aim to revolutionize the industry through innovative solutions.

PRISM uses innovative peptide mimic technology to create therapeutic drugs that effectively treat challenging diseases. Their mission is to develop cures for these conditions through advanced research and development.

Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of ​​cancer with high unmet medical need.

PRISM uses innovative peptide mimic technology to create therapeutic drugs that effectively treat challenging diseases. Their mission is to develop cures for these conditions through advanced research and development.

Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of ​​cancer with high unmet medical need.

Scohia Pharma is a cutting-edge biotech startup with a focus on research and development. With substantial resources, they aim to revolutionize the industry through innovative solutions.

FIMECS is dedicated to creating innovative protein degradation therapies for challenging diseases like cancer. Their focus is on developing cutting-edge treatments that target specific proteins to improve outcomes for patients.

PRISM uses innovative peptide mimic technology to create therapeutic drugs that effectively treat challenging diseases. Their mission is to develop cures for these conditions through advanced research and development.

Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of ​​cancer with high unmet medical need.

Catalys Pacific, founded in 2019, is an independent venture capital firm specializing in early-stage investments in life sciences. Their focus is on creating and investing in bioventure companies to provide innovative healthcare solutions for patients globally.